US FDA panel backs booster shot for elderly, high risk groups
The decision late Friday came after members of the FDA`s Vaccines and Related Biological Products Advisory Committee voted against advising the agency to approve boosters for anyone 16 and older after hours of debate, reports Xinhua news agency.
Members of the committee expressed doubts about the safety of a booster dose in younger adults and teens, and said they wanted to see more data about the safety and long term efficacy of a booster dose. Source: Reuters